Shah Capital’s Activism at VEON, Letter to Board of Directors
Himanshu H. Shah Managing Partner and Chief Investment Officer SHAH CAPITAL OPPORTUNITY FUND LPApril 14, 20235% Shareholder’s Roadmap to $100 Share PriceVEON Board of Directors,As a long-term shareholder owning over Read More >>
Marius Pharmaceuticals Receives FDA Approval of KYZATREX™, an Oral Testosterone Replacement Therapy
Marius Pharmaceuticals, a patient-centric healthcare company, today announced the approval of KYZATREX™ (testosterone undecanoate) by the U.S. Food and Drug Administration (FDA). KYZATREX™ is an oral testosterone replacement therapy (“TRT”) Read More >>
ReneSola Announces a Repurchase Transaction with ReneSola Singapore and Enters into a New Investor Rights Agreement with Shah Capital
NEWS PROVIDED BY ReneSola Ltd.Sep 02, 2022, 09:00 ET –Share Repurchase from ReneSola Singapore–New Investor Rights Agreement with Shah Capital–Departure of Two Board Members STAMFORD, Conn., Sept. 2, 2022 /PRNewswire/ — ReneSola Ltd Read More >>
Himanshu H. Shah joins ReneSola Power as a Director
STAMFORD, Conn., March 23, 2022 /PRNewswire/ — ReneSola Ltd (“ReneSola Power” or the “Company”) (www.renesolapower.com) (NYSE: SOL), a leading fully integrated solar project developer, today announced that Sam Feng has Read More >>
Top Ten Holdings of Himanshu Shah
Himanshu H. Shah is the founder, president and chief investment officer of Shah Capital Management. Shah founded Shah Capital Management in 2005 after working at UBS for ten years. Shah Read More >>
Marius Pharmaceuticals Receives PDUFA Date for KYZATREX® NDA for Treatment of Hypogonadism
RALEIGH, N.C., March 11, 2021 – Marius Pharmaceuticals announced today that the U.S. Food and Drug Administration (FDA) has assigned a Prescription Drug User Fee Act (PDUFA) goal date of Read More >>
Marius Seeks FDA Approval of Testosterone Therapy
Raleigh-based Marius Pharmaceuticals, led by several former GlaxoSmithKline scientists and executives, is making progress on its first potential drug.Marius has submitted a New Drug Application (NDA) to the U.S. Food and Read More >>
Vitamin Shoppe to Appoint New Independent Directors to Board
SECAUCUS, N.J., April 23, 2018 SECAUCUS, N.J., April 23, 2018 /PRNewswire/ — Vitamin Shoppe, Inc. (NYSE: VSI), an omni-channel, specialty retailer and contract manufacturer of nutritional products, today announced that Read More >>